Cite
HARVARD Citation
Ketteler, M. et al. (2023). Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trial. Nephrology dialysis transplantation. 38 (4), pp. 982-991. [Online].